MedTrace Logo

Characterization of the Use of Antipsychotics in Posttraumatic Stress Disorder During the Past Decade

NCT00233467 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2017-09-14

No results posted yet for this study

Summary

The main purpose is to show the percentage of patients taking antipsychotics with PTSD by looking at approximately ten year's worth of data from 1994 through 2004. We will also determine the type and dose of antipsychotics the patients received, and to determine how many of those patients had psychotic versus nonpsychotic symptoms. We will be obtaining this data from the VISN 7 Corporate Data Warehouse. We hypothesize that there has been an overall increase in antipsychotic use in patient's with PTSD over the last 10 years.

Conditions

Sponsors & Collaborators

  • Tuscaloosa Research & Education Advancement Corporation

    lead OTHER

Principal Investigators

  • Rebecca Seamans, PharmD · Tuscaloosa Veterans Affairs Medical Center

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-01
Primary Completion
2005-09-30
Completion
2005-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00233467 on ClinicalTrials.gov